Effectiveness of increasing alcohol excise taxes in the management of alcohol-associated liver disease in China

Feiyu ZHANG; Peng XIAO; Yali LIU; Tao LIU; Yanhang GAO

doi:10.3969/j.issn.1001-5256.2023.07.027

Volume 39 Issue 7

Jul. 2023

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2023 > 39(7): 1703-1707

PDF( 1707 KB)

Effectiveness of increasing alcohol excise taxes in the management of alcohol-associated liver disease in China

DOI: 10.3969/j.issn.1001-5256.2023.07.027

Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, China

Research funding:

National Natural Science Foundation of China (81972265);

National Natural Science Foundation of China (82170602);

National Natural Science Foundation of Jilin Province (20200201324JC);

Project for Health Talents of Jilin Province (JLSWSRCZX 2021-079)

More Information

Corresponding author: GAO Yanhang, yanhang@mail.jlu.edu.cn (ORCID: 0000-0002-7248-8290)
Received Date: 2022-10-23
Accepted Date: 2022-11-25
Published Date: 2023-07-20

Abstract

Abstract

Increasing alcohol excise taxes has been confirmed by the World Health Organization as the most cost-effective public policy for reducing alcohol consumption at the population level. In recent years, studies in foreign countries have believed that increasing alcohol excise taxes can improve the burden of alcohol-associated liver disease (ALD), but it is still unclear whether this policy is applicable to ALD management in China. Therefore, with reference to related research evidence in China and globally, this article analyzes the key factors influencing the effectiveness of the policy of increasing alcohol excise taxes from the perspective of ALD management in China, including tax shifting, price elasticity of demand, and unrecorded alcohol, and introduces other public policies that help curb ALD. We think that increasing alcohol excise taxes is currently a useful but not effective policy for improving the burden of ALD in China.
- Liver Diseases, Alcoholic,
- Alcohol Drinking,
- Excise tax

FullText(HTML)

References(38)

References

[1]	World Health Organization. World health statistics 2022: monitoring health for the SDGs, sustainable development goals[EB/OL]. (2022-05-19)[2022-10-1]. https://www.who.int/publications/i/item/9789240051157.
[2]	World Health Organization. Global status report on alcohol and health 2018[EB/OL]. (2018-09-27)[2022-10-1]. https://www.who.int/publications/i/item/9789241565639.
[3]	XU H, XIAO P, ZHANG F, et al. Epidemic characteristics of alcohol-related liver disease in Asia from 2000 to 2020: A systematic review and meta-analysis[J]. Liver Int, 2022, 42(9): 1991-1998. DOI: 10.1111/liv.15312.
[4]	World Health Organization. Global strategy to reduce the harmful use of alcohol[EB/OL]. (2010-05-31)[2022-10-1]. https://www.who.int/publications/i/item/9789241599931.
[5]	ASRANI SK, MELLINGER J, ARAB JP, et al. Reducing the global burden of alcohol-associated liver disease: A blueprint for action[J]. Hepatology, 2021, 73(5): 2039-2050. DOI: 10.1002/hep.31583.
[6]	PONICKI WR, GRUENEWALD PJ. The impact of alcohol taxation on liver cirrhosis mortality[J]. J Stud Alcohol, 2006, 67(6): 934-938. DOI: 10.15288/jsa.2006.67.934.
[7]	SHEN NT, BRAY J, WAHID NA, et al. Evaluation of alcohol taxes as a public health opportunity to reduce liver transplant listings for alcohol-related liver disease[J]. Alcohol Clin Exp Res, 2020, 44(11): 2307-2315. DOI: 10.1111/acer.14454.
[8]	WILSON LB, PRYCE R, ANGUS C, et al. The effect of alcohol tax changes on retail prices: how do on-trade alcohol retailers pass through tax changes to consumers?[J]. Eur J Health Econ, 2021, 22(3): 381-392. DOI: 10.1007/s10198-020-01261-1.
[9]	ALLY AK, MENG Y, CHAKRABORTY R, et al. Alcohol tax pass-through across the product and price range: do retailers treat cheap alcohol differently?[J]. Addiction, 2014, 109(12): 1994-2002. DOI: 10.1111/add.12590.
[10]	PARIKH ND, CHUNG GS, MELLINGER J, et al. Alcohol policies and alcohol-related liver disease mortality[J]. Gastroenterology, 2021, 161(1): 350-352. DOI: 10.1053/j.gastro.2021.03.031.
[11]	FEI MQ, LIU J, HUANG J. Discussion on liquor consumption taxation in China[J]. Tax Res, 2021(9): 37-42. DOI: 10.19376/j.cnki.cn11-1011/f.2021.09.006. 费茂清, 刘佳, 黄江. 关于我国白酒消费税的探讨[J]. 税务研究, 2021(9): 37-42. DOI: 10.19376/j.cnki.cn11-1011/f.2021.09.006.
[12]	WAGENAAR AC, SALOIS MJ, KOMRO KA. Effects of beverage alcohol price and tax levels on drinking: a meta-analysis of 1003 estimates from 112 studies[J]. Addiction, 2009, 104(2): 179-190. DOI: 10.1111/j.1360-0443.2008.02438.x.
[13]	TIAN G, LIU F. Is the demand for alcoholic beverages in developing countries sensitive to price? Evidence from China[J]. Int J Environ Res Public Health, 2011, 8(6): 2124-2131. DOI: 10.3390/ijerph8062124.
[14]	ZHAO Z, WANG L, ZHANG M, et al. Geographic distribution of alcohol use among Chinese adults - China, 2015[J]. China CDC Wkly, 2020, 2(7): 98-103.
[15]	SHI Y. Three essays on economics of health behavior in China[CD]. Ann Arbor: The Pardee RAND Graduate School, 2011.
[16]	WANG H, MA L, YIN Q, et al. Prevalence of alcoholic liver disease and its association with socioeconomic status in north-eastern China[J]. Alcohol Clin Exp Res, 2014, 38(4): 1035-1041. DOI: 10.1111/acer.12321.
[17]	EWING SW, SAKHARDANDE A, BLAKEMORE SJ. The effect of alcohol consumption on the adolescent brain: A systematic review of MRI and fMRI studies of alcohol-using youth[J]. Neuroimage Clin, 2014, 5: 420-437. DOI: 10.1016/j.nicl.2014.06.011.
[18]	WALLER R, MURRAY L, SHAW DS, et al. Accelerated alcohol use across adolescence predicts early adult symptoms of alcohol use disorder via reward-related neural function[J]. Psychol Med, 2019, 49(4): 675-684. DOI: 10.1017/S003329171800137X.
[19]	GALLET CA. The demand for alcohol: a meta-analysis of elasticities[J]. Aust J Agric Res Econ, 2007, 51(2): 121-135. DOI: 10.1111/j.1467-8489.2007.00365.x.
[20]	MEIER PS, PURSHOUSE R, BRENNAN A. Policy options for alcohol price regulation: the importance of modelling population heterogeneity[J]. Addiction, 2010, 105(3): 383-393. DOI: 10.1111/j.1360-0443.2009.02721.x.
[21]	BLACK H, GILL J, CHICK J. The price of a drink: levels of consumption and price paid per unit of alcohol by Edinburgh's ill drinkers with a comparison to wider alcohol sales in Scotland[J]. Addiction, 2011, 106(4): 729-736. DOI: 10.1111/j.1360-0443.2010.03225.x.
[22]	AYYAGARI P, DEB P, FLETCHER J, et al. Understanding heterogeneity in price elasticities in the demand for alcohol for older individuals[J]. Health Econ, 2013, 22(1): 89-105. DOI: 10.1002/hec.1817.
[23]	NELSON JP. Gender differences in alcohol demand: a systematic review of the role of prices and taxes[J]. Health Econ, 2014, 23(10): 1260-1280. DOI: 10.1002/hec.2974.
[24]	MÄKELÄ P, PALJÄRVI T. Do consequences of a given pattern of drinking vary by socioeconomic status? A mortality and hospitalisation follow-up for alcohol-related causes of the Finnish Drinking Habits Surveys[J]. J Epidemiol Community Health, 2008, 62(8): 728-733. DOI: 10.1136/jech.2007.065672.
[25]	PROBST C, KILIAN C, SANCHEZ S, et al. The role of alcohol use and drinking patterns in socioeconomic inequalities in mortality: a systematic review[J]. Lancet Public Health, 2020, 5(6): e324-324e332. DOI: 10.1016/S2468-2667(20)30052-9.
[26]	SASSI F, BELLONI A, MIRELMAN AJ, et al. Equity impacts of price policies to promote healthy behaviours[J]. Lancet, 2018, 391(10134): 2059-2070. DOI: 10.1016/S0140-6736(18)30531-2.
[27]	LACHENMEIER DW, GMEL G, REHM J. Unrecorded alcohol consumption[J]. Alcohol: science, policy, and public health, 2013: 132-142.
[28]	NEWMAN IM, QIAN L, TAMRAKAR N, et al. Chemical composition and safety of unrecorded grain alcohol (Bai Jiu) samples from three provinces in China[J]. Int J Environ Res Public Health, 2018, 15(12): 2710. DOI: 10.3390/ijerph15122710.
[29]	WEI S, YIN P, NEWMAN IM, et al. Comparison of patterns of use of unrecorded and recorded spirits: Survey of adult drinkers in rural central China[J]. Int J Environ Res Public Health, 2017, 14(10): 1099. DOI: 10.3390/ijerph14101099.
[30]	World Health Organization. Unrecorded alcohol: what the evidence tells us[EB/OL]. (2022-03-21)[2022-10-1]. https://www.who.int/publications/i/item/9789240044463.
[31]	NEWMAN I, QIAN L, TAMRAKAR N, et al. Composition of unrecorded distilled alcohol (bai jiu) produced in small rural factories in central China[J]. Alcohol Clin Exp Res, 2017, 41(1): 207-215. DOI: 10.1111/acer.13280.
[32]	QIAN L, NEWMAN IM, XIONG W, et al. Traditional grain alcohol (bai jiu, [Symbol: see text]) production and use in rural central China: implications for public health[J]. BMC Public Health, 2015, 15: 1261. DOI: 10.1186/s12889-015-2594-4.
[33]	LACHENMEIER DW. Reducing harm from alcohol: what about unrecorded products?[J]. Lancet, 2009, 374(9694): 977. DOI: 10.1016/S0140-6736(09)61661-5.
[34]	NEMTSOV AV. Mortality in Russia in light of the in alcohol consumption[J]. Demographic review, 2015, 2(4): 111-135.
[35]	DING L, SONG B, WU C, et al. Alcohol use in China: Unrecorded and recorded bai jiu in three rural regions[J]. Int J Environ Res Public Health, 2021, 19(1): 405. DOI: 10.3390/ijerph19010405.
[36]	ANDERSON P, O'DONNELL A, KANER E, et al. Impact of minimum unit pricing on alcohol purchases in Scotland and Wales: controlled interrupted time series analyses[J]. Lancet Public Health, 2021, 6(8): e557-e565. DOI: 10.1016/S2468-2667(21)00052-9.
[37]	LEAL-LÓPEZ E, MORENO-MALDONADO C, INCHLEY J, et al. Association of alcohol control policies with adolescent alcohol consumption and with social inequality in adolescent alcohol consumption: A multilevel study in 33 countries and regions[J]. Int J Drug Policy, 2020, 84: 102854. DOI: 10.1016/j.drugpo.2020.102854.
[38]	AVANCEÑA A, MILLER N, UTTAL SE, et al. Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis[J]. J Hepatol, 2021, 74(6): 1286-1294. DOI: 10.1016/j.jhep.2020.12.004.

Relative Articles

[1]	Haijian DONG, Hui LI, Yujing TAO, Jialing GUO, Yuru ZHONG, Zijian ZENG. Role of A-kinase anchor protein 12 in chronic liver diseases[J]. Journal of Clinical Hepatology, 2023, 39(3): 718-722. doi: 10.3969/j.issn.1001-5256.2023.03.037
[2]	Ming WANG, Jianhu XU, Li MA. Mechanism of action of Dange Jiecheng decoction in a rat model of alcoholic liver disease based on the Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 signaling pathway[J]. Journal of Clinical Hepatology, 2023, 39(5): 1119-1125. doi: 10.3969/j.issn.1001-5256.2023.05.018
[3]	Yanhong BAO, Qiang WANG, Wenlong ZHANG, Na GE, Nan LI, Jun SU, Kexin LI. Ursolic acid in Hippophae rhamnoides L. inhibits hepatocyte apoptosis in rats with alcoholic liver disease by regulating mitochondria-cytochrome c[J]. Journal of Clinical Hepatology, 2023, 39(7): 1617-1626. doi: 10.3969/j.issn.1001-5256.2023.07.016
[4]	Cheng MA, Hui YANG. Role of the nuclear factor erythroid 2-related factor 2/heme oxygenase-1 signaling pathway in alcoholic liver disease[J]. Journal of Clinical Hepatology, 2023, 39(7): 1708-1713. doi: 10.3969/j.issn.1001-5256.2023.07.028
[5]	Boyuan GU, Shengyou XIAO, Chen LIU, Yonglang CHENG, Wenguang FU. Research advances in the role of Enterococcus faecalis in alcoholic liver disease[J]. Journal of Clinical Hepatology, 2023, 39(7): 1696-1702. doi: 10.3969/j.issn.1001-5256.2023.07.026
[6]	Qun ZHOU, Hua ZHANG, Ping LIU, Jiamei CHEN. Role of Takeda G protein-coupled receptor-5 in non-viral liver diseases[J]. Journal of Clinical Hepatology, 2022, 38(9): 2172-2176. doi: 10.3969/j.issn.1001-5256.2022.09.043
[7]	Rui ZHANG, Xiujuan CHANG, Jiamin CHENG, Zhiqin ZHAO, Yinyin LI, Yinying LU, Zhen ZENG. Influence of high-density lipoprotein cholesterol on the prognosis of patients with alcohol-related hepatocellular carcinoma after radical treatment[J]. Journal of Clinical Hepatology, 2021, 37(3): 621-626. doi: 10.3969/j.issn.1001-5256.2021.03.023
[8]	Qian WANG, Chunyan CHANG, Song YANG. Research advances in alcoholic liver disease with sarcopenia[J]. Journal of Clinical Hepatology, 2021, 37(8): 1943-1947. doi: 10.3969/j.issn.1001-5256.2021.08.043
[9]	Hui QUAN, Yuyong JIANG. Role of interleukin-1β in the pathogenesis of alcoholic liver disease[J]. Journal of Clinical Hepatology, 2021, 37(5): 1226-1228. doi: 10.3969/j.issn.1001-5256.2021.05.053
[10]	Chinese Medical Association, Chinese Medical Journals Publishing House, Chinese Society of Gastroenterology, Chinese Medical Association, Chinese Society of General Practice, Chinese Medical Association, Editorial Board of Chinese Journal of General Practitioners of Chinese Medical Association, Expert Group of Guidelines for Primary Care of Gastrointestinal Disease. Guideline for primary care of alcoholic liver disease(2019)[J]. Journal of Clinical Hepatology, 2021, 37(1): 36-40. doi: 10.3969/j.issn.1001-5256.2021.01.008
[11]	Niu ChunYan, Liu Qin, Luo XiaoChun. Reexamination of the diagnosis of fatty liver disease under the background of disease spectrum progression[J]. Journal of Clinical Hepatology, 2020, 36(10): 2356-2359. doi: 10.3969/j.issn.1001-5256.2020.10.043
[12]	NIU ChunYan, ZHANG Qiang, ZHAO XiangYang. Influence of drinking on nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(11): 2593-2596. doi: 10.3969/j.issn.1001-5256.2020.11.044
[14]	Liu Chen, Xing HuiChun, Cheng Jun, Yang Song. Influence of drinking on progression of chronic hepatitis B and outcome of antiviral therapy[J]. Journal of Clinical Hepatology, 2019, 35(3): 472-475. doi: 10.3969/j.issn.1001-5256.2019.03.003
[15]	Ma JiaLi, He LingLing, Li Ping, Jiang Yu, Hu JuLong, Zhou YuLing, Liang XiuXia, Wei HongShan. Influence of alcohol consumption on liver function and rebleeding in alcoholic cirrhotic patients with esophageal and gastric varices[J]. Journal of Clinical Hepatology, 2019, 35(11): 2478-2482. doi: 10.3969/j.issn.1001-5256.2019.11.018
[18]	Li QianNan, Chang JianBo, Bai YanXia, Wan Yan, Bi JianHong, Dai GuangRong. An epidemiological survey of alcoholic liver disease among staff of Yanchang Oilfield[J]. Journal of Clinical Hepatology, 2017, 33(9): 1769-1773. doi: 10.3969/j.issn.1001-5256.2017.09.029
[19]	Shen Wei. Alcohol consumption, metabolic syndrome and liver cancer [J]. Journal of Clinical Hepatology, 2010, 26(3): 255-256.

Supplements(0)

Cited By

Cited by

Periodical cited type(2)

1.	王念，黄利思，张转玲，张森，刘潇逸，徐龙舟，朱一丹，余新炳，黄艳. 枯草芽孢杆菌表达人ADH1B和ALDH2及其活性与稳定性研究. 热带医学杂志. 2024(05): 617-622 .
2.	寇文涛，刘芝荃. 欧洲三国限酒令对国民健康及经济发展的影响分析与启示. 食品工业. 2024(06): 337-341 .

Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (353) PDF downloads(36)

Effectiveness of increasing alcohol excise taxes in the management of alcohol-associated liver disease in China

DOI: 10.3969/j.issn.1001-5256.2023.07.027